JP2000502052A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000502052A5 JP2000502052A5 JP1997519395A JP51939597A JP2000502052A5 JP 2000502052 A5 JP2000502052 A5 JP 2000502052A5 JP 1997519395 A JP1997519395 A JP 1997519395A JP 51939597 A JP51939597 A JP 51939597A JP 2000502052 A5 JP2000502052 A5 JP 2000502052A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19543649.0 | 1995-11-23 | ||
| DE19543649A DE19543649C2 (de) | 1995-11-23 | 1995-11-23 | Tumorvakzine und Verfahren zu ihrer Herstellung |
| DE19607044A DE19607044A1 (de) | 1996-02-24 | 1996-02-24 | Tumorvakzine und Verfahren zu ihrer Herstellung |
| DE19607044.9 | 1996-02-24 | ||
| PCT/EP1996/005126 WO1997019169A1 (de) | 1995-11-23 | 1996-11-21 | Tumorvakzine und verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000502052A JP2000502052A (ja) | 2000-02-22 |
| JP2000502052A5 true JP2000502052A5 (enExample) | 2004-10-21 |
Family
ID=26020603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9519395A Abandoned JP2000502052A (ja) | 1995-11-23 | 1996-11-21 | 腫瘍ワクチン及びその製造方法 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20020085997A1 (enExample) |
| EP (1) | EP0866851A1 (enExample) |
| JP (1) | JP2000502052A (enExample) |
| KR (1) | KR19990067653A (enExample) |
| CN (1) | CN1202931A (enExample) |
| AR (1) | AR004341A1 (enExample) |
| AU (1) | AU720131B2 (enExample) |
| BG (1) | BG62999B1 (enExample) |
| BR (1) | BR9611466A (enExample) |
| CA (1) | CA2238176A1 (enExample) |
| CO (1) | CO4520254A1 (enExample) |
| CZ (1) | CZ158998A3 (enExample) |
| EE (1) | EE03778B1 (enExample) |
| HU (1) | HUP0000318A3 (enExample) |
| NO (1) | NO982329D0 (enExample) |
| NZ (1) | NZ322910A (enExample) |
| PL (1) | PL188537B1 (enExample) |
| RO (1) | RO115275B1 (enExample) |
| RU (1) | RU2206329C2 (enExample) |
| SK (1) | SK66998A3 (enExample) |
| TR (1) | TR199800912T2 (enExample) |
| TW (1) | TW514530B (enExample) |
| UY (2) | UY24367A1 (enExample) |
| WO (1) | WO1997019169A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO4600681A1 (es) † | 1996-02-24 | 1998-05-08 | Boehringer Ingelheim Pharma | Composicion farmaceutica para la modulacion inmunitaria |
| CA2278678A1 (en) * | 1997-01-31 | 1998-08-06 | Research Corporation Technologies, Inc. | Cancer immunotherapy with semi-allogeneic cells |
| EP0904786B1 (en) * | 1997-08-22 | 2004-12-15 | Science Park Raf S.p.A. | Tumor vaccination by use of autologous or HLA-related antigen presenting cell (APC) transduced with a tumour antigen and a foreign antigen capable of causing an immune reaction |
| US7014848B1 (en) | 1998-03-20 | 2006-03-21 | Genzyme Corporation | Enhanced anti-tumor immunity |
| CA2322660A1 (en) * | 1998-03-20 | 1999-09-23 | Genzyme Corporation | Enhanced anti-tumor immunity |
| FR2807661A1 (fr) * | 2000-04-14 | 2001-10-19 | Univ Nantes | Agent et procede pour la simulation de lymphocytes t specifiques et lymphocytes t obtenus |
| EP1473564A4 (en) * | 2001-09-18 | 2008-12-10 | Greenpeptide Co Ltd | METHOD FOR DETECTING CELL IMMUNITY AND ITS APPLICATION TO MEDICAMENTS |
| RU2203683C1 (ru) * | 2001-09-20 | 2003-05-10 | НИИ онкологии им. проф. Н.Н. Петрова | Способ иммунотерапии костно-мозговыми дендритными клетками больных солидными опухолями |
| GB0209896D0 (en) | 2002-04-30 | 2002-06-05 | Molmed Spa | Conjugate |
| CN1315536C (zh) * | 2002-09-13 | 2007-05-16 | 李进 | 肿瘤抗原疫苗及其制备方法和疫苗组合物 |
| GB0224442D0 (en) | 2002-10-21 | 2002-11-27 | Molmed Spa | A delivery system |
| EP1667711B1 (en) * | 2003-08-25 | 2010-07-28 | UniVax, LLC | Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) |
| RU2267326C2 (ru) * | 2004-03-16 | 2006-01-10 | ГУН НИИ онкологии им. проф. Н.Н. Петрова Минздрава РФ | Способ иммунотерапии опухолевым лизатом с адъювантом беталейкин больных солидными опухолями |
| US7674456B2 (en) * | 2004-06-14 | 2010-03-09 | Charles Wiseman | Breast cancer cell lines and uses thereof |
| CN101163503B (zh) * | 2005-02-23 | 2013-05-08 | 健泰科生物技术公司 | 使用her二聚化抑制剂在癌症患者中延长病情进展前时间或存活 |
| US20090214494A1 (en) * | 2005-03-29 | 2009-08-27 | The Board Of Trustees Of The University Of Illinoi | Cancer Vaccines and Therapeutic Methods |
| DK1760088T3 (da) * | 2005-09-05 | 2008-06-09 | Immatics Biotechnologies Gmbh | Tumor associerede peptider, der bindes promiskuöst til human leuko-cyt-antigen (HLA) klasse II-molekyler |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| WO2011101465A1 (en) | 2010-02-19 | 2011-08-25 | Intercell Ag | Ic31 nanoparticles |
| AU2013289939B2 (en) * | 2012-07-12 | 2018-08-09 | Persimmune, Inc. | Personalized cancer vaccines and adoptive immune cell therapies |
| JP6710004B2 (ja) | 2016-03-15 | 2020-06-17 | Ｒｅｐｅｒｔｏｉｒｅ Ｇｅｎｅｓｉｓ株式会社 | 免疫療法のためのモニタリングまたは診断ならびに治療剤の設計 |
| WO2018208856A1 (en) | 2017-05-08 | 2018-11-15 | Gritstone Oncology, Inc. | Alphavirus neoantigen vectors |
| KR20220016137A (ko) | 2019-05-30 | 2022-02-08 | 그릿스톤 바이오, 인코포레이티드 | 변형된 아데노바이러스 |
| WO2022032196A2 (en) | 2020-08-06 | 2022-02-10 | Gritstone Bio, Inc. | Multiepitope vaccine cassettes |
| CA3211645A1 (en) * | 2021-03-12 | 2022-09-15 | Erika VON EUW | Methods of enhancing diversity of hla haplotype expression in tumors to broaden tumor cell susceptibility to tcr-t therapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235525B1 (en) * | 1991-05-23 | 2001-05-22 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
| JPH05246889A (ja) * | 1992-03-05 | 1993-09-24 | Seitai Chiyousetsu Kenkyusho:Kk | 制癌方法および制癌剤 |
| EP0569678A3 (de) * | 1992-03-13 | 1994-10-26 | Yeda Res & Dev | Mit MHC-Genen doppelt transfizierte Zellen als Impfstoffe zur Immunoprevention von Tumormetastasen. |
-
1996
- 1996-11-19 UY UY24367A patent/UY24367A1/es not_active IP Right Cessation
- 1996-11-21 US US09/077,214 patent/US20020085997A1/en not_active Abandoned
- 1996-11-21 HU HU0000318A patent/HUP0000318A3/hu unknown
- 1996-11-21 RU RU98111622/14A patent/RU2206329C2/ru not_active IP Right Cessation
- 1996-11-21 EP EP96939870A patent/EP0866851A1/de not_active Withdrawn
- 1996-11-21 SK SK669-98A patent/SK66998A3/sk unknown
- 1996-11-21 JP JP9519395A patent/JP2000502052A/ja not_active Abandoned
- 1996-11-21 CN CN96198493A patent/CN1202931A/zh active Pending
- 1996-11-21 AU AU76947/96A patent/AU720131B2/en not_active Ceased
- 1996-11-21 WO PCT/EP1996/005126 patent/WO1997019169A1/de not_active Ceased
- 1996-11-21 PL PL96326756A patent/PL188537B1/pl not_active IP Right Cessation
- 1996-11-21 CA CA002238176A patent/CA2238176A1/en not_active Abandoned
- 1996-11-21 CZ CZ981589A patent/CZ158998A3/cs unknown
- 1996-11-21 RO RO98-00985A patent/RO115275B1/ro unknown
- 1996-11-21 NZ NZ322910A patent/NZ322910A/xx unknown
- 1996-11-21 TR TR1998/00912T patent/TR199800912T2/xx unknown
- 1996-11-21 EE EE9800161A patent/EE03778B1/xx not_active IP Right Cessation
- 1996-11-21 BR BR9611466A patent/BR9611466A/pt not_active Application Discontinuation
- 1996-11-21 KR KR1019980703681A patent/KR19990067653A/ko not_active Ceased
- 1996-11-22 AR ARP960105291A patent/AR004341A1/es not_active Application Discontinuation
- 1996-11-22 CO CO96061701A patent/CO4520254A1/es unknown
- 1996-11-23 TW TW085114455A patent/TW514530B/zh not_active IP Right Cessation
-
1997
- 1997-01-03 UY UY24430A patent/UY24430A1/es not_active IP Right Cessation
-
1998
- 1998-05-08 BG BG102439A patent/BG62999B1/bg unknown
- 1998-05-22 NO NO982329A patent/NO982329D0/no unknown